The economic impact of treatment of severe lupus nephritis with prednisone and intravenous cyclophosphamide.

scientific article published in July 1994

The economic impact of treatment of severe lupus nephritis with prednisone and intravenous cyclophosphamide. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/ART.1780370704
P698PubMed publication ID8024609

P2093author name stringKlippel JH
Schuttinga J
Stark SP
McInnes PM
Sanslone WR
P433issue7
P921main subjectlupus nephritisQ1621830
P304page(s)1000-1006
P577publication date1994-07-01
P1433published inArthritis & RheumatologyQ4797636
P1476titleThe economic impact of treatment of severe lupus nephritis with prednisone and intravenous cyclophosphamide.
P478volume37

Reverse relations

cites work (P2860)
Q41926859A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group
Q48675363Brain glucose utilization in systemic lupus erythematosus with neuropsychiatric symptoms: A controlled positron emission tomography study
Q48517160Neuropsychiatric systemic lupus erythematosus before and after immunosuppressive treatment: a FDG PET study
Q34004185Pulse intravenous cyclophosphamide therapy for dermatologic disorders
Q51084575Quality of life and economic evaluation in SLE clinical trials.
Q40506580Systemic lupus erythematosus--disease management
Q33658733The value of electron microscopy in the diagnosis and clinical management of lupus nephritis
Q70994785Undiagnosed systemic lupus erythematosus in the community
Q33893383Update on cyclophosphamide for systemic lupus erythematosus
Q78679215[Current therapy of lupus nephritis]

Search more.